In conclusion, the current study demonstrated that alpinetin behaved as a PXR ligand and decreased the susceptibility of mice to DSS-induced colitis via a mechanism associated with PXR-mediated anti-inflammation and detoxification. This evidence concerns the gene NR1I2 and colitis.